AnalystBook Research · Company Intelligence

Enact Holdings, Inc.

ACTNasdaq

Built from Enact Holdings, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Enact kept revenue and equity growing, but net income slipped while buybacks and insider sales rose.

The read at a glance✓ Audited against SEC data
  • Business mixPrivate mortgage insurer in all 50 statesNote
  • RevenueRevenue +2.8% to $1.24BOK
  • ProfitabilityNet income -2.0% to $674MWatch
  • CapitalDividends +8.2% to $121MOK
  • BuybacksBuybacks +56.7% to $382MWatch
  • Balance sheetEquity +7.2% to $5.36BOK
  • Insiders0 buys / 18 sellsWatch

Business

Enact is a private mortgage insurance company serving the U.S. housing finance market, with policies that protect lenders and investors on low-down-payment mortgage loans.

Leadership changes

From Enact Holdings, Inc.'s own filings, the day they're filed.

  • K. H. Elizabeth Mitchell · appointmenteff. 2025-03-11
  • Anne G. Waleski · Directors · departureeff. 2025-03-07
  • Anne G. Waleski · director · appointment

Latest filings

  • 10-Q · Quarterly report2026-08-06
  • 8-K · Company announcement2026-08-05
  • 8-K · Company announcement2026-05-15
  • 10-Q · Quarterly report2026-05-06
  • 8-K · Company announcement2026-05-05
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Enact Holdings, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.